4Filed Aug 26, 8:00 PM ET

Forte (FBRX) CEO Paul Wagner Sells/Converts ~2.04M Shares in Merger

$FBRX · Forte Biosciences, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Forte (FBRX) CEO Paul Wagner Sells/Converts ~2.04M Shares in Merger

What Happened
Paul A. Wagner (CEO, Secretary and Chair of the Board) disposed of a total of 2,039,758 units on 2026-08-27 in connection with Forte’s acquisition by argenx. This includes 85,482 shares tendered in the change-of-control offer and multiple derivative dispositions (RSUs/options) that were cancelled/converted under the Merger Agreement. Under the tender offer and merger, common shares tendered and outstanding RSUs were exchanged for $77.00 per share in cash; option treatment depended on each option’s strike (in‑the‑money options were settled for the spread, out‑of‑the‑money options were cancelled per the agreement).

Key Details

  • Transaction date: 2026-08-27 (all entries) — Form 4 filed same day.
  • Reported disposals: 2,039,758 total units (85,482 common shares + multiple derivative items including RSUs and options).
  • Consideration: Common stock tendered and RSUs were paid $77.00 per share (footnotes F1 and F4). In‑the‑money options were cashed out for the spread per the merger terms (footnote F2); option-specific exercise prices are not shown on this Form 4.
  • Transaction codes: “U” = disposition in change of control (tendered shares); “D” = disposition to issuer (derivative cancellations/conversions).
  • Estimated value: If all 2,039,758 units were paid at $77 (note: option payouts vary), the gross amount would be roughly $157.06 million; actual cash received for option cancellations may be different.
  • Shares owned after transaction: The filing does not list remaining Forte common shares/awards; most reported holdings were converted or cancelled pursuant to the Merger Agreement.
  • Filing timeliness: Reported and filed on 2026-08-27 (no late filing indicated).

Context

  • This activity reflects the closing of a merger (argenx BV acquired Forte). It is a corporate-change transaction, not a typical open‑market sale. RSUs are defined as contingent rights to one share (footnote F3) and were cashed out at the merger price.
  • For options: cash received equals the spread between the $77 merger price and the option strike for in‑the‑money options; out‑of‑the‑money options were cancelled with no payment per the merger terms.
  • For retail investors: these disposals were driven by the corporate acquisition mechanics rather than a routine insider sale; they do not necessarily signal insider sentiment about the business going forward.